Serum Amyloid a promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells

Malle, 1993, Serum amyloid A (SAA): an acute phase protein and apolipoprotein, Atherosclerosis, 102, 131, 10.1016/0021-9150(93)90155-N Uhlar, 1999, Serum amyloid A, the major vertebrate acute-phase reactant, Eur. J. Biochem., 265, 501, 10.1046/j.1432-1327.1999.00657.x Urieli-Shoval, 2000, Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states, Curr. Opin. Hematol., 7, 64, 10.1097/00062752-200001000-00012 Salazar, 2001, Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders, Eur. J. Clin. Invest., 31, 1070, 10.1046/j.1365-2362.2001.00913.x Clifton, 1985, Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction, J. Lipid Res., 26, 1389, 10.1016/S0022-2275(20)34244-9 Turnell, 1986, Secondary structure prediction of human SAA1 presumptive identification of calcium and lipid binding sites, Mol. Biol. Med., 3, 387 Segrest, 1976, Amyloid A: amphipathic helixes and lipid binding, Biochemistry, 15, 3187, 10.1021/bi00660a005 Segrest, 1994, The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins, Adv. Protein Chem., 45, 303, 10.1016/S0065-3233(08)60643-9 Meek, 1994, Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function, Proc. Natl. Acad. Sci. USA, 91, 3186, 10.1073/pnas.91.8.3186 Kisilevsky, 2002, Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease, Pediatr. Pathol. Mol. Med., 21, 291, 10.1080/02770930290056523 Salazar, 2000, Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis, Atherosclerosis, 152, 497, 10.1016/S0021-9150(00)00368-3 Hosoai, 1999, Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-Itransgenic mice, J. Lipid Res., 40, 648, 10.1016/S0022-2275(20)32143-X Banka, 1995, Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux, J. Lipid Res., 36, 1058, 10.1016/S0022-2275(20)39863-1 Artl, 2000, Role of serum amyloid A during metabolism of acute-phase HDL by macrophages, Arterioscler. Thromb. Vasc. Biol., 20, 763, 10.1161/01.ATV.20.3.763 Yamada, 1997, Effect of serum amyloid A on cellular affinity of low density lipoprotein, Eur. J. Clin. Chem. Clin. Biochem., 35, 421 Kisilevsky, 1992, Serum amyloid A changes high density lipoprotein’s cellular affinity. A clue to serum amyloid A’s principal function, Lab. Invest., 66, 778 Liang, 1996, Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aorticsmooth muscle and HepG2 cells, J. Lipid Res., 37, 2109, 10.1016/S0022-2275(20)37293-X Liang, 1995, Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux, J. Lipid Res., 36, 37, 10.1016/S0022-2275(20)39752-2 Tam, 2002, Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1, J. Lipid Res., 43, 1410, 10.1194/jlr.M100388-JLR200 Kisilevsky, 2003, Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1, J. Lipid Res., 44, 2257, 10.1194/jlr.M300133-JLR200 Tall, 2002, Regulation and mechanisms of macrophage cholesterol efflux, J. Clin. Invest., 110, 899, 10.1172/JCI0216391 Fielding, 2001, Cellular cholesterol efflux, Biochim. Biophys. Acta, 1533, 175, 10.1016/S1388-1981(01)00162-7 Oram, 2002, The cholesterol mobilizing transporter ABCA1 as a new therapeutic target for cardiovascular disease, Trends Cardiovasc. Med., 12, 170, 10.1016/S1050-1738(02)00159-7 Remaley, 1999, Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred, Proc. Natl. Acad. Sci. USA, 96, 12685, 10.1073/pnas.96.22.12685 Remaley, 2001, Apolipoprotein specificity for lipid efflux by the human ABCAI transporter, Biochem. Biophys. Res. Commun., 280, 818, 10.1006/bbrc.2000.4219 Remaley, 2003, Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway, J. Lipid Res., 44, 828, 10.1194/jlr.M200475-JLR200 Eriksen, 1986, Serum amyloid A (ApoSAA) and lipoproteins, Methods Enzymol., 128, 311, 10.1016/0076-6879(86)28076-3 Brewer, 1986, Isolation and characterization of apolipoproteins A-I, A-II, and A-IV, Methods Enzymol., 128, 223, 10.1016/0076-6879(86)28070-2 Jonas, 1986, Reconstitution of high-density lipoproteins, Methods Enzymol., 128, 553, 10.1016/0076-6879(86)28092-1 Remaley, 1997, Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux, Arterioscler. Thromb. Vasc. Biol., 17, 1813, 10.1161/01.ATV.17.9.1813 Takahashi, 2000, Identification of cAMP analogue inducible genes in RAW264 macrophages, Biochim. Biophys. Acta, 1492, 385, 10.1016/S0167-4781(00)00133-0 Miida, 1999, Serum amyloid A protein generates pre beta 1 high-density lipoprotein from alpha-migrating high-density lipoprotein, Biochemistry, 38, 16958, 10.1021/bi9913045